Immunoglobulins (particularly IgG levels and/or IgM and IgA) can also be used to assess pemphigus severity, and anti‐drug antibodies allow for the monitoring of treatment efficacy and development of drug resistance.9, 10. This evidence concerns the gene CD79A and pemphigus.